FTFinancial Times·1hBusiness
score+0.30
Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars
Original
Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars
“Headline highlights soaring demand and raised profits, but summary introduces investor concern over business model reliance.”